Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Mills

Showing results (161-170 of 242) with videos related to

Pageof 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumorsD M Gershenson, M Deavers, S Diaz, et al.
Transplantation|August 27, 1994
Evidence that increases in lymphocyte tyrosine phosphorylation precede cardiac allograft rejection. Effects of cyclosporine and potential use in clinical managementP W Tsao, G B Mills, R J Diaz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2013
Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapyJ Sohn, K A Do, S Liu, et al.
Leukemia|September 1, 1990
Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cellsA C Schuh, D R Sutherland, W Horsfall, et al.
The Journal of Biological Chemistry|August 5, 1992
Expression of TTK, a novel human protein kinase, is associated with cell proliferationG B Mills, R Schmandt, M McGill, et al.
Oncogene|October 5, 2010
Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epitheliumJ Suo, S J Snider, G B Mills, et al.
The Journal of Biological Chemistry|June 29, 2001
Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activityB B Wolf, M Schuler, W Li, et al.
Nature Genetics|January 23, 1999
PIK3CA is implicated as an oncogene in ovarian cancerL Shayesteh, Y Lu, W L Kuo, et al.
Oncogene|January 18, 2012
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibitionA Astanehe, M R Finkbeiner, M Krzywinski, et al.
Oncogene|July 16, 2013
Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancerN Panupinthu, S Yu, D Zhang, et al.
Pageof 25

Showing results (161-170 of 242) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumorsD M Gershenson, M Deavers, S Diaz, et al.
Transplantation|August 27, 1994
Evidence that increases in lymphocyte tyrosine phosphorylation precede cardiac allograft rejection. Effects of cyclosporine and potential use in clinical managementP W Tsao, G B Mills, R J Diaz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2013
Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapyJ Sohn, K A Do, S Liu, et al.
Leukemia|September 1, 1990
Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cellsA C Schuh, D R Sutherland, W Horsfall, et al.
The Journal of Biological Chemistry|August 5, 1992
Expression of TTK, a novel human protein kinase, is associated with cell proliferationG B Mills, R Schmandt, M McGill, et al.
Oncogene|October 5, 2010
Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epitheliumJ Suo, S J Snider, G B Mills, et al.
The Journal of Biological Chemistry|June 29, 2001
Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activityB B Wolf, M Schuler, W Li, et al.
Nature Genetics|January 23, 1999
PIK3CA is implicated as an oncogene in ovarian cancerL Shayesteh, Y Lu, W L Kuo, et al.
Oncogene|January 18, 2012
MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibitionA Astanehe, M R Finkbeiner, M Krzywinski, et al.
Oncogene|July 16, 2013
Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancerN Panupinthu, S Yu, D Zhang, et al.
Pageof 25